glp-1 news october 1 2025 GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Compound versions of GLP-1 drugs

The ASA24 shows a visual example of portion sizes, which reflect more accurate reporting for the 3-day food record

People with a personal or family history of medullary thyroid cancer or people with multiple endocrine neoplasia syndrome Type 2 (MEN 2) are advised against taking Ozempic because animal studies found an association between semaglutide and medullary thyroid tumors

& Shiota, K

Based on published Phase 2 trial data, the most common adverse events are gastrointestinal: nausea (up to 46%), diarrhea (up to 33%), vomiting (up to 22%), and decreased appetite (up to 22%)

Can breast changes be reversed naturally

The study also found that the rate of weight regain after stopping the drugs is almost four times faster than after diet and physical activity changes alone, irrespective of the amount of weight lost during treatment